Login / Signup

Review article: experimental therapies in autoimmune hepatitis.

Neil HallidayJessica Katharine DysonDouglas ThorburnAnsgar W LohseMichael A Heneghan
Published in: Alimentary pharmacology & therapeutics (2020)
With the range of tools available to clinicians and patients increasing, it is likely that the therapeutic landscape of AIH will change over the coming years and treatment approaches offering lower corticosteroid use and aiming to restore immune self-tolerance should be sought.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • multiple sclerosis
  • palliative care
  • patient reported outcomes
  • drug induced